UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.083
NA - Nord America 5.824
EU - Europa 2.847
SA - Sud America 804
Continente sconosciuto - Info sul continente non disponibili 303
AF - Africa 121
OC - Oceania 17
Totale 16.999
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.543
HK - Hong Kong 3.897
SG - Singapore 1.391
IT - Italia 1.366
BR - Brasile 627
CN - Cina 537
VN - Vietnam 489
RU - Federazione Russa 309
DE - Germania 279
FR - Francia 164
BD - Bangladesh 152
CA - Canada 136
TR - Turchia 118
IE - Irlanda 110
IN - India 110
FI - Finlandia 102
GB - Regno Unito 96
SE - Svezia 80
KR - Corea 79
AR - Argentina 77
UA - Ucraina 77
NL - Olanda 58
AT - Austria 54
ID - Indonesia 46
JP - Giappone 45
MX - Messico 43
ZA - Sudafrica 43
IQ - Iraq 35
PL - Polonia 31
ES - Italia 29
CZ - Repubblica Ceca 25
JM - Giamaica 25
PK - Pakistan 23
EC - Ecuador 22
CR - Costa Rica 21
IL - Israele 21
CO - Colombia 20
SA - Arabia Saudita 17
UZ - Uzbekistan 17
MY - Malesia 14
CL - Cile 13
MA - Marocco 12
PH - Filippine 12
PY - Paraguay 12
AL - Albania 11
AU - Australia 11
NP - Nepal 11
TN - Tunisia 11
VE - Venezuela 11
HN - Honduras 10
IS - Islanda 10
AZ - Azerbaigian 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 9
GT - Guatemala 8
PE - Perù 8
TT - Trinidad e Tobago 8
EE - Estonia 7
EG - Egitto 7
SC - Seychelles 7
TH - Thailandia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
KG - Kirghizistan 6
SV - El Salvador 6
DZ - Algeria 5
GR - Grecia 5
OM - Oman 5
PR - Porto Rico 5
ET - Etiopia 4
LB - Libano 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
IR - Iran 3
RO - Romania 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BJ - Benin 2
BN - Brunei Darussalam 2
GD - Grenada 2
GM - Gambi 2
GY - Guiana 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 16.664
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.892
San Jose 791
Singapore 683
Milan 454
Ashburn 448
Dallas 413
Ann Arbor 377
Chandler 304
Council Bluffs 292
Princeton 274
Munich 192
Naples 163
Beijing 155
Ho Chi Minh City 133
Los Angeles 126
New York 124
Lauterbourg 122
The Dalles 122
Hanoi 114
Rome 113
Santa Clara 102
Dublin 100
Jacksonville 92
Dong Ket 91
Izmir 91
Moscow 75
Wilmington 72
Houston 66
São Paulo 63
Andover 56
Pellezzano 52
Nuremberg 45
Helsinki 44
Tokyo 40
Salerno 36
Chicago 35
Orem 35
Turku 34
Phoenix 33
Vienna 33
Nanjing 32
Toronto 32
Boardman 31
Denver 31
Atlanta 30
Figino 30
Woodbridge 30
Brooklyn 29
Warsaw 28
Montreal 24
Brno 23
Fisciano 23
San Francisco 23
Boston 22
Haiphong 22
Memphis 21
Poplar 20
Turin 20
Fairfield 19
Amsterdam 18
Columbus 18
Nanchang 18
Pune 18
Rio de Janeiro 18
Buffalo 17
Chennai 17
Manchester 17
Mexico City 17
Changsha 16
Frankfurt am Main 16
Newark 16
Philadelphia 16
Johannesburg 15
San José 15
Tashkent 15
Biên Hòa 14
Bologna 14
Brasília 14
Norwalk 14
Shanghai 14
Da Nang 13
Kingston 13
Seattle 13
Seoul 13
Washington 13
Baghdad 12
London 12
Mumbai 12
Paris 12
Sarno 12
Stockholm 12
Charlotte 11
Lappeenranta 11
Quito 11
Belo Horizonte 10
Jakarta 10
Reykjavik 10
San Diego 10
Baku 9
Cape Town 9
Totale 11.542
Salva come PNG Salva come JPEG
Nome #
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 623
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 619
Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series 549
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 528
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 508
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 433
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 347
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 272
Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review 266
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 265
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 215
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 208
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 204
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 171
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 163
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 163
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 161
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 160
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in advanced cancer patients treated with anti-PD-1/PD-L1 therapy 160
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 160
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 158
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 152
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 151
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 146
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 145
Abstract 3639: Combinatorial therapy for triple negative breast cancer 145
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 140
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 135
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 134
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies 132
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 129
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 127
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 125
PD-L1 Dysregulation in COVID-19 Patients 124
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 122
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 121
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 121
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 121
Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know 120
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 120
Blocking the formation of radiation-induced breast cancer stem cells 120
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 119
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 119
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 119
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 117
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. 117
Counteracting resistance to treatments in solid tumors. 116
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 115
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 113
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 112
Multidisciplinary approach to patient with malignant melanoma 112
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 111
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 110
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 109
Epigenetic control of gene expression: Potential implications for cancer treatment 106
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 106
Surgical Treatment, Rehabilitative Approaches and Functioning Assessment for Patients Affected by Breast Cancer-Related Lymphedema: A Comprehensive Review 105
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 104
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 103
Clinical and genetic drivers of oligo-metastatic disease in colon cancer 102
Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice 102
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 102
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 102
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 100
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 99
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 99
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 98
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 98
Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: Report of the first case 97
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 97
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 97
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 94
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 92
EXPLORING AUTONOMIC NERVOUS SYSTEM RESPONSES DURING COGNITIVE STRESS TEST FOR AUTOMATIC PAIN ASSESSMENT IN CANCER PATIENTS 91
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 90
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 90
The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis 89
Harnessing host innate immunity may combat acquired resistance to BRAFi 89
Emerging BRAF inhibitors for melanoma 88
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 87
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives 86
Melanoma initiating cells: where do we stand? 86
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 86
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 85
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 84
Testing egfr with idylla on cytological specimens of lung cancer: A review 83
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain 83
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 80
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 80
Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer 79
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 78
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 78
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 77
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 77
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study 76
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 76
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 76
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies 75
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 75
Genetic evolution of T-cell resistance in the course of melanoma progression 75
Totale 14.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 0 0 0 0 22 5 2 19 79 50 66 209
2022/2023752 77 80 68 128 55 144 1 48 98 1 42 10
2023/2024555 41 42 37 37 37 59 44 29 35 37 29 128
2024/20251.792 44 17 28 66 90 195 322 138 335 141 198 218
2025/202610.072 792 2.229 1.769 681 741 432 977 233 488 646 292 792
2026/20272.054 400 300 605 680 69 0 0 0 0 0 0 0
Totale 16.999